Why Choose dgd Research

Largest, privately owned endocrine and metabolic research organization in the United States.
Over 20 years pharmaceutical clinical trial experience with over 1500 Phase I-IV research studies performed in diabetes, hypertension, neuropathy, osteoporosis, cholesterol, obesity, menopause, and nephropathy.
Dedicated research team consisting of Physicians, Registered Nurses, Nurse Practitioners, Registered Dieticians, and Physician Assistants.
World-class customer base comprised of the top 50 global pharmaceutical and biotechnology companies
Leads the U.S. market in Phase I endocrine and metabolic trials-rated first choice for Phase I endocrine studies by leading pharmaceutical and biotechnology companies.
Two optimal research locations in San Antonio, Texas, provide exceptional access to distinct patient populations consisting of diabetic and obese patients.
Exclusive database access to over 55,000 patients from the Diabetes & Glandular Disease Clinic-the largest endocrinology practice in the United States.
Industry leader in rapidly and appropriately filling endocrine and metabolic research studies.
Phase I-IV research facilities complete with state-of-the-art equipment and expertise for all endocrine/metabolic clinical measurements and testing.
Planned expansion for a new 80,000 sq. ft., 100 bed Phase I-IV research facility.
Strong community ties and advertising relationships with the San Antonio Spurs, H-E-B Grocery, as well as local television affiliates.
Internal Regulatory and QA departments
Corporate infrastructure with CEO/CMO, COO, and Controller